A major addition to the Buffalo Niagara Medical Campus is beginning to take its final form. Installation of the blue glass on the 10-story Global Vascular Institute and Clinical & Transitional Research Center/Incubator, a joint venture between the University at Buffalo and Kaleida Health is nearing completion. The $291 million facility aims to transform Buffalo into a “world-class health care destination”. The center will form a collaborative effort between Kaleida Health physicians and UB researchers to provide advanced medical care, vascular disease treatment breakthroughs, and development of local biotechnology business opportunities.
The two-year construction project, designed by Canon Design, will open in 2011 and advance the UB 2020 strategic plan to relocate the health sciences programs to downtown Buffalo. It is estimated that this expansion of UB will draw 13,000 UB faculty, staff, and students to downtown.